CROSSJECT competitors & alternatives

ARS Pharmaceuticals, Inc.SPRY · PharmaceuticalsSan Diego, United States

66% matchPublic

Similar pharmaceuticals company

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.

Similar pharmaceuticals company

Vivani Medical, Inc. is a clinical-stage biopharmaceutical company that specializes in developing innovative implantable medical devices. The firm aims to address chronic diseases for which current treatments are insufficient or lacking. Its key initiatives include a portfolio of miniature drug implants, designed to ensure consistent and stable therapeutic drug delivery, as well as advanced implantable visual prostheses intended to provide meaningful artificial vision to blind individuals. Vivani Medical is headquartered in Emeryville, California.

KiOmed PharmaPharmaceuticalsBelgium

61% match

Similar pharmaceuticals company

KiOmed Pharma is a Belgian biotechnology company that develops, manufactures, and distributes injectable medical devices based on an exclusive natural chitosan derivative called KiOmedine CM-chitosan. The company serves patients and medical professionals by creating therapeutic solutions and aesthetic products to address osteoarthritis, skin aging, and eye diseases.

UPSAPharmaceuticals

61% match

Similar pharmaceuticals company

UPSA is a French pharmaceutical laboratory that manufactures and provides over-the-counter medications, medical devices, and dietary supplements to help patients treat common, everyday ailments. The company operates across six main therapeutic areas, including pain and fever, ENT, digestion, sleep, women's health, and vitality.

Adamed Pharma S.A.PharmaceuticalsPoland

61% match

Similar pharmaceuticals company

Adamed Pharma S.A. is a pharmaceutical and biotechnology company that researches, develops, and manufactures prescription drugs, over-the-counter medicines, dietary supplements, dermocosmetics, and medical devices. It serves patients across multiple therapeutic areas globally, utilizing its own scientific research and patents.

Similar pharmaceuticals company

EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom. Among its commercialized product portfolio are ILUVIEN, an injectable, sustained-release micro-insert designed to treat diabetic macular edema, and YUTIQ, an intravitreal implant containing fluocinolone acetonide, which targets chronic non-infectious uveitis impacting the posterior segment of the eye. The company also offers DEXYCU, a dexamethasone intraocular suspension, utilized to manage post-operative ocular inflammation, such as that occurring after cataract surgery. Looking ahead, EyePoint is actively developing several pipeline therapies. This includes EYP-1901, a novel, bioerodible tyrosine kinase inhibitor currently formulated for twice-yearly administration, which is under development for conditions like wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. Additionally, YUTIQ50 is being advanced as a treatment for chronic non-infectious uveitis affecting the posterior region of the eye. To bolster its market reach and development efforts, the company maintains strategic alliances with entities such as Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. Furthermore, a commercial collaboration with ImprimisRx PA, Inc. specifically focuses on the joint promotion of DEXYCU for inflammation following ocular surgery. Incorporated in 1987, the organization was previously known as pSivida Corp. before officially rebranding as EyePoint Pharmaceuticals, Inc. in March 2018. Its corporate headquarters are situated in Watertown, Massachusetts.

Biotechnology

Bioneedle Drug Delivery B.V., headquartered at the Leiden Bio Science Park in the Netherlands, was formed in 2004 to develop an innovative vaccination and drug delivery technology.

Biotechnology

Eyenovia, Inc. is a New York-based ophthalmic technology and pharmaceutical manufacturing company focused on targeted drug-delivery solutions for eye care using its proprietary Optejet device.

VivaniBiotechUnited States

64% match

Biotech

Vivani is a biopharmaceutical company that develops miniaturized, subdermal drug implants utilizing its proprietary NanoPortal platform technology to provide steady, long-term medication delivery for chronic conditions like obesity and type 2 diabetes. Additionally, through its subsidiary Cortigent, the company develops targeted neurostimulation systems designed to help patients recover critical body functions such as vision and movement.

MERCATOR MEDSYSTEMS INCMedical TechnologyUnited States

63% matchPrivate

Medical Technology

Mercator MedSystems, Inc. is a medical device company headquartered in San Leandro, California, that develops specialized catheter systems for targeted drug delivery.

Biora TherapeuticsBiotechnologyUnited States

63% match

Biotechnology

Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.

Micron Biomedical, Inc.BiotechnologyUnited States

62% matchPrivate

Biotechnology

Micron Biomedical, Inc. is a clinical-stage biopharmaceutical and life science company committed to expanding global access to therapeutics and vaccines formulated into proprietary array-based delivery technologies.